China Supplier Fujimycin - CAS 928672-86-0 Purity ≥99.0% (HPLC) API – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

We normally think and practice corresponding towards the change of circumstance, and grow up. We aim at the achievement of a richer mind and body plus the living for 20277-69-4, C7H9ClN2O, Atorvastatin Calcium CAS 134523-03-8, Our professional technological team will be wholeheartedly at your services. We sincerely welcome you to definitely take a look at our website and enterprise and send out us your inquiry.
China Supplier Fujimycin - CAS 928672-86-0 Purity ≥99.0% (HPLC) API – Ruifu Detail:

9

Chemical Name Canagliflozin Hemihydrate
CAS Number 928672-86-0
CAT Number RF-API22
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C24H27FO6S
Molecular Weight 462.53
Brand Ruifu Chemical
Item Specifications
Appearance White Powder
Identification HPLC/NMR
Solubility Very Soluble in methanol; Soluble in ethanol, acetonitrile; Slightly soluble in water
Purity / Analysis Method ≥99.0% (HPLC)
Individual Impurity ≤0.10%
Total Impurities ≤0.50%
Residual Solvents
Methanol ≤3000ppm
Ethanol ≤5000ppm
Acetonitrile ≤400ppm
Dichloromethane ≤600ppm
Ethyl Acetate ≤5000ppm
THF ≤720ppm
Toluene ≤890ppm
Test Standard Chinese Pharmacopoeia (CP); Enterprise Standard
Usage Active Pharmaceutical Ingredient (API); SGLT-2 inhibitors Type 2 Diabetes

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1

Canagliflozin is a drug of the gliflozin class or subtype 2 sodium-glucose transport inhibitors (SGLT2) used for the treatment of type 2 diabetes.  It was developed by Mitsubishi Tanabe Pharma and is marketed under license by Janssen, a division of Johnson & Johnson. Canagliflozin is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine. In March 2013, canagliflozin became the first SGLT2 inhibitor to be approved in the United States.

Canagliflozin, to mention the advantage, this drug helps patients to reduce blood sugars without increasing the likelihood of gaining weight as long as a healthy, balanced diet is followed and regular exercise taken. In addition, Canagliflozin has a broad prospect due to its significant antiobesity effects and few hypoglycemic events.


Product detail pictures:

China Supplier Fujimycin - CAS 928672-86-0 Purity ≥99.0% (HPLC) API – Ruifu detail pictures


Related Product Guide:

Good quality comes initial; company is foremost; small business is cooperation" is our business philosophy which is frequently observed and pursued by our business for China Supplier Fujimycin - CAS 928672-86-0 Purity ≥99.0% (HPLC) API – Ruifu , The product will supply to all over the world, such as: New Zealand, Brisbane, United States, We hope we can establish long-term cooperation with all of the customers, and hope we can improve competitiveness and achieve the win-win situation together with the customers. We sincerely welcome the customers from all over the world to contact us for anything you need to have!Welcome all customers both at home and abroad to visit our factory. We hope to have win-win business relationships with you, and create a better tomorrow.
  • The supplier abide the theory of "quality the basic, trust the first and management the advanced" so that they can ensure a reliable product quality and stable customers.
    5 Stars By Lydia from Guatemala - 2018.12.25 12:43
    In our cooperated wholesalers, this company has the best quality and reasonable price, they are our first choice.
    5 Stars By Dora from Italy - 2018.09.23 18:44
    Write your message here and send it to us